The economy is suffering, but your health doesn’t have to.

One way to save on medical costs? Choosing generic alternatives to prescription medications.

Some drugs, however, have yet to be replicated because their patents are still in-tact. These drugs, and their 2007 sales figures, include:

1: Prevacid (antiulcerant): $3.4 Billion
2: Risperdal (schizophrenia): $2.6 Billion
3: Topamax (anticonvulsant): $2.1 Billion
4: Lamictal (anticonvulsant) $2.0 Billion
5: Fosamax (osteoporosis): $1.9 Billion
6: Valtrex (antiviral): $1.5 Billion
7: Aciphex (antiulcerant): $1.29 Billion
8: Imitrex (migraines): $1.28 Billion
9: Adderall XR (attention deficit): $1.26 Billion
10: Concerta (attention defictit): $1.0 Billion

(Source: Merrill Lynch Generic Perspectives)

The good news? Each of these drugs has patents that will expire by the end of 2009, says Charlie Mayr, a spokesman for the Generic Pharmaceutical Association.

And likely will follow the generic adaptations.

If you liked this article you might like

Preventative Steps Can Stop Investment Scams

Preventative Steps Can Stop Investment Scams

Part-time Job Finder: Consider Mary Kay

Part-time Job Finder: Consider Mary Kay

What Every Child (and Parent) Should Know About Saving

What Every Child (and Parent) Should Know About Saving

The Budget Bride: Save on Flowers

The Budget Bride: Save on Flowers

How to Swim Out from an Underwater Mortgage

How to Swim Out from an Underwater Mortgage